These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24259397)

  • 1. Left atrial appendage occlusion in octogenarians: short-term and 1-year follow-up.
    Gafoor S; Franke J; Bertog S; Boehm P; Heuer L; Gonzaga M; Bauer J; Braut A; Lam S; Vaskelyte L; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):805-10. PubMed ID: 24259397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplatzer left atrial appendage occlusion: single center 10-year experience.
    Nietlispach F; Gloekler S; Krause R; Shakir S; Schmid M; Khattab AA; Wenaweser P; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):283-9. PubMed ID: 23412815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.
    Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
    Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.
    Gloekler S; Shakir S; Doblies J; Khattab AA; Praz F; Guerios Ê; Koermendy D; Stortecky S; Pilgrim T; Buellesfeld L; Wenaweser P; Windecker S; Moschovitis A; Jaguszewski M; Landmesser U; Nietlispach F; Meier B
    Clin Res Cardiol; 2015 Aug; 104(8):656-65. PubMed ID: 25736061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous closure of the left atrial appendage: a new option for the prevention of thromboembolic stroke].
    Oto A; Aytemir K; Okutucu S; Kaya EB; Sahiner L; Sabanov C; Evranos B
    Turk Kardiyol Dern Ars; 2011 Dec; 39(8):668-74. PubMed ID: 22257805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device.
    Jaguszewski M; Manes C; Puippe G; Salzberg S; Müller M; Falk V; Lüscher T; Luft A; Alkadhi H; Landmesser U
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):306-12. PubMed ID: 25205611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Appendage Occlusion for Stroke Prevention.
    Chanda A; Reilly JP
    Prog Cardiovasc Dis; 2017; 59(6):626-635. PubMed ID: 28457791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
    Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry.
    Betts TR; Leo M; Panikker S; Kanagaratnam P; Koa-Wing M; Davies DW; Hildick-Smith D; Wynne DG; Ormerod O; Segal OR; Chow AW; Todd D; Cabrera Gomez S; Kirkwood GJ; Fox D; Pepper C; Foran J; Wong T
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):484-492. PubMed ID: 27651124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
    Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage closure.
    Lin AC; Knight BP
    Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedural success and intra-hospital outcome related to left atrial appendage morphology in patients that receive an interventional left atrial appendage closure.
    Fastner C; Behnes M; Sartorius B; Wenke A; El-Battrawy I; Ansari U; Gill IS; Borggrefe M; Akin I
    Clin Cardiol; 2017 Aug; 40(8):566-574. PubMed ID: 28409845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
    Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of a global registry to evaluate real-world clinical outcomes in patients with atrial fibrillation and high risk of stroke treated with left atrial appendage occlusion using the AMPLATZER amulet device-Perspective of available/ongoing registries of catheter-based LAA occlusion.
    Hildick-Smith D; Diener HC; Schmidt B; Paul V; Settergren M; Teiger E; Camm J; Tondo C; Landmesser U
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):540-547. PubMed ID: 28862376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous left atrial appendage occlusion: Effect of device positioning on outcome.
    Wolfrum M; Attinger-Toller A; Shakir S; Gloekler S; Seifert B; Moschovitis A; Khattab A; Maisano F; Meier B; Nietlispach F
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):656-664. PubMed ID: 27465268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.